Literature DB >> 30880068

Extending the scope of PARP inhibitors in ovarian cancer.

Jonathan A Ledermann1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30880068     DOI： 10.1016/S1470-2045(19)30019-1

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  6 in total

Review 1.  The Development of 18F Fluorthanatrace: A PET Radiotracer for Imaging Poly (ADP-Ribose) Polymerase-1.

Authors:  Hsiaoju S Lee; Sally W Schwarz; Erin K Schubert; Delphine L Chen; Robert K Doot; Mehran Makvandi; Lilie L Lin; Elizabeth S McDonald; David A Mankoff; Robert H Mach
Journal:  Radiol Imaging Cancer       Date:  2022-01

Review 2.  The tubal epigenome - An emerging target for ovarian cancer.

Authors:  Hunter D Reavis; Ronny Drapkin
Journal:  Pharmacol Ther       Date:  2020-03-18       Impact factor: 12.310

3.  Anti-Tumor Xanthones from Garcinia nujiangensis Suppress Proliferation, and Induce Apoptosis via PARP, PI3K/AKT/mTOR, and MAPK/ERK Signaling Pathways in Human Ovarian Cancers Cells.

Authors:  Zhongyan Tang; Lihua Lu; Zhengxiang Xia
Journal:  Drug Des Devel Ther       Date:  2020-09-25       Impact factor: 4.162

4.  PHY34 inhibits autophagy through V-ATPase V0A2 subunit inhibition and CAS/CSE1L nuclear cargo trafficking in high grade serous ovarian cancer.

Authors:  Amrita Salvi; Alexandria N Young; Andrew C Huntsman; Melissa R Pergande; Melissa A Korkmaz; Rathnayake A Rathnayake; Brittney K Mize; A Douglas Kinghorn; Xiaoli Zhang; Kiira Ratia; Markus Schirle; Jason R Thomas; Scott M Brittain; Claude Shelton; Leslie N Aldrich; Stephanie M Cologna; James R Fuchs; Joanna E Burdette
Journal:  Cell Death Dis       Date:  2022-01-10       Impact factor: 8.469

5.  Therapeutic vulnerability to PARP1,2 inhibition in RB1-mutant osteosarcoma.

Authors:  Georgia Zoumpoulidou; Carlos Alvarez-Mendoza; Caterina Mancusi; Ritika-Mahmuda Ahmed; Milly Denman; Christopher D Steele; Maxime Tarabichi; Errin Roy; Lauren R Davies; Jiten Manji; Camilla Cristalli; Katia Scotlandi; Nischalan Pillay; Sandra J Strauss; Sibylle Mittnacht
Journal:  Nat Commun       Date:  2021-12-03       Impact factor: 14.919

Review 6.  Biomarkers of Central Nervous System Involvement from Epithelial Ovarian Cancer.

Authors:  Giulia Scotto; Fulvio Borella; Margherita Turinetto; Valentina Tuninetti; Anna A Valsecchi; Gaia Giannone; Stefano Cosma; Chiara Benedetto; Giorgio Valabrega
Journal:  Cells       Date:  2021-12-03       Impact factor: 6.600
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.